DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,841 | -4.0% | 67,883 | -7.1% | 0.48% | +9.4% |
| Q2 2023 | $17,536 | -26.1% | 73,069 | -22.4% | 0.44% | -12.1% |
| Q1 2023 | $23,736 | -24.8% | 94,177 | -20.8% | 0.50% | -10.8% |
| Q4 2022 | $31,573 | -99.9% | 118,956 | -0.4% | 0.56% | -4.5% |
| Q3 2022 | $30,856,000 | +2.4% | 119,466 | +0.2% | 0.58% | +8.6% |
| Q2 2022 | $30,146,000 | -4.7% | 119,221 | +10.5% | 0.54% | +13.1% |
| Q1 2022 | $31,641,000 | -10.8% | 107,871 | 0.0% | 0.47% | -5.8% |
| Q4 2021 | $35,490,000 | -10.0% | 107,871 | -16.8% | 0.50% | -1.0% |
| Q3 2021 | $39,449,000 | +12.1% | 129,581 | -1.1% | 0.51% | +13.7% |
| Q2 2021 | $35,178,000 | +22.0% | 131,087 | +2.4% | 0.45% | +12.6% |
| Q1 2021 | $28,827,000 | -8.9% | 128,075 | -10.1% | 0.40% | -4.3% |
| Q4 2020 | $31,637,000 | -3.5% | 142,420 | -6.5% | 0.41% | -10.4% |
| Q3 2020 | $32,786,000 | +24.6% | 152,260 | +2.3% | 0.46% | +14.6% |
| Q2 2020 | $26,314,000 | +26.6% | 148,813 | -0.9% | 0.40% | +2.8% |
| Q1 2020 | $20,782,000 | -9.2% | 150,155 | +0.7% | 0.39% | +12.6% |
| Q4 2019 | $22,877,000 | +2.1% | 149,061 | -3.9% | 0.35% | -6.5% |
| Q3 2019 | $22,406,000 | +1.7% | 155,136 | +0.6% | 0.37% | +1.1% |
| Q2 2019 | $22,040,000 | +8.0% | 154,216 | -0.2% | 0.37% | +3.7% |
| Q1 2019 | $20,403,000 | +34.8% | 154,549 | +5.3% | 0.36% | +18.7% |
| Q4 2018 | $15,132,000 | -34.4% | 146,749 | -30.9% | 0.30% | +9.5% |
| Q3 2018 | $23,067,000 | +16.3% | 212,288 | +5.6% | 0.27% | +9.6% |
| Q2 2018 | $19,835,000 | +2.8% | 201,012 | +2.0% | 0.25% | -0.4% |
| Q1 2018 | $19,289,000 | +5.8% | 197,012 | +0.3% | 0.25% | +7.8% |
| Q4 2017 | $18,238,000 | +8.2% | 196,492 | 0.0% | 0.23% | +2.2% |
| Q3 2017 | $16,855,000 | +2.9% | 196,492 | +1.2% | 0.23% | -2.6% |
| Q2 2017 | $16,387,000 | -1.2% | 194,192 | +0.2% | 0.23% | -3.7% |
| Q1 2017 | $16,583,000 | +13.1% | 193,892 | +2.9% | 0.24% | +7.6% |
| Q4 2016 | $14,665,000 | -0.6% | 188,412 | +0.1% | 0.22% | -5.9% |
| Q3 2016 | $14,753,000 | -21.3% | 188,212 | +1.4% | 0.24% | -24.1% |
| Q2 2016 | $18,746,000 | +7.1% | 185,612 | +0.6% | 0.32% | +6.4% |
| Q1 2016 | $17,502,000 | +3.5% | 184,512 | +1.3% | 0.30% | +0.7% |
| Q4 2015 | $16,913,000 | +11.4% | 182,092 | +2.2% | 0.29% | +3.2% |
| Q3 2015 | $15,188,000 | -1.7% | 178,242 | -1.3% | 0.28% | +5.9% |
| Q2 2015 | $15,457,000 | +1.0% | 180,592 | +0.2% | 0.27% | -1.5% |
| Q1 2015 | $15,308,000 | -0.7% | 180,302 | +0.3% | 0.27% | 0.0% |
| Q4 2014 | $15,409,000 | +13.9% | 179,784 | +1.0% | 0.27% | +9.2% |
| Q3 2014 | $13,528,000 | -3.4% | 178,044 | +0.1% | 0.25% | -3.1% |
| Q2 2014 | $14,000,000 | +12.3% | 177,824 | +7.0% | 0.26% | +6.2% |
| Q1 2014 | $12,465,000 | -1.5% | 166,203 | +1.3% | 0.24% | -3.6% |
| Q4 2013 | $12,660,000 | – | 163,992 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |